Mikio Kido
Overview
Explore the profile of Mikio Kido including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Muraoka H, Kodaka F, Hasegawa N, Yasui-Furukori N, Fukumoto K, Kashiwagi H, et al.
Asian J Psychiatr
. 2022 Jun;
74:103174.
PMID: 35661492
Purpose: In the treatment guidelines for major depressive disorder (MDD), the recommended treatment differs based on the severity. However, the type of treatment provided based on the severity of MDD...
12.
Hori H, Yasui-Furukori N, Hasegawa N, Iga J, Ochi S, Ichihashi K, et al.
Front Psychiatry
. 2022 Jun;
13:823826.
PMID: 35656353
In several clinical guidelines for schizophrenia, long-term use of anticholinergic drugs is not recommended. We investigated the characteristics of the use of anticholinergics in patients with schizophrenia by considering psychotropic...
13.
Yamada H, Motoyama M, Hasegawa N, Miura K, Matsumoto J, Ohi K, et al.
BJPsych Open
. 2022 Apr;
8(3):e83.
PMID: 35446248
Background: Clinical practice guidelines for schizophrenia and major depressive disorder have been published. However, these have not had sufficient penetration in clinical settings. We developed the Effectiveness of Guidelines for...
14.
Ogasawara K, Numata S, Hasegawa N, Nakataki M, Makinodan M, Ohi K, et al.
Neuropsychopharmacol Rep
. 2022 Mar;
42(2):221-225.
PMID: 35272393
The Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE) project, which is a nationwide dissemination and implementation program for clinical practice guidelines (CPGs) in the field of...
15.
Ichihashi K, Kyou Y, Hasegawa N, Yasui-Furukori N, Shimizu Y, Hori H, et al.
Asian J Psychiatr
. 2022 Jan;
69:103007.
PMID: 35051727
Background: Although several guidelines indicate that daily pharmacotherapy is an important part of the treatment of schizophrenia and major depressive disorder, there are few reports regarding pro re nata (PRN)...
16.
Pham T, Sasabayashi D, Takahashi T, Takayanagi Y, Kubota M, Furuichi A, et al.
Front Aging Neurosci
. 2022 Jan;
13:752575.
PMID: 35002674
Previous magnetic resonance imaging (MRI) studies reported increased brain gyrification in schizophrenia and schizotypal disorder, a prototypic disorder within the schizophrenia spectrum. This may reflect deviations in early neurodevelopment; however,...
17.
Takayanagi Y, Kulason S, Sasabayashi D, Takahashi T, Katagiri N, Sakuma A, et al.
Cereb Cortex
. 2021 Oct;
32(10):2245-2253.
PMID: 34649274
Although some individuals with at-risk mental states (ARMS) develop overt psychosis, surrogate markers which can reliably predict a future onset of psychosis are not well established. The dorsal lateral prefrontal...
18.
Takahashi T, Sasabayashi D, Takayanagi Y, Furuichi A, Kido M, Nakamura M, et al.
Schizophr Res
. 2021 Sep;
237:174-181.
PMID: 34536751
Background: Reduced gray matter volumes in the superior temporal gyrus and its subregions, such as Heschl's gyrus (HG) and the planum temporale (PT), have been reported in schizophrenia (Sz). However,...
19.
Sasabayashi D, Takayanagi Y, Takahashi T, Nishiyama S, Mizukami Y, Katagiri N, et al.
Transl Psychiatry
. 2021 Jul;
11(1):396.
PMID: 34282119
Although widespread cortical thinning centered on the fronto-temporal regions in schizophrenia has been reported, the findings in at-risk mental state (ARMS) patients have been inconsistent. In addition, it remains unclear...
20.
Takahashi T, Sasabayashi D, Takayanagi Y, Higuchi Y, Mizukami Y, Nishiyama S, et al.
Front Behav Neurosci
. 2021 May;
15:647069.
PMID: 33958991
An increased prevalence of duplicated Heschl's gyrus (HG), which may reflect an early neurodevelopmental pathology, has been reported in schizophrenia (Sz). However, it currently remains unclear whether individuals at risk...